1. Home
  2. FULT vs PBLS Comparison

FULT vs PBLS Comparison

Compare FULT & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulton Financial Corporation

FULT

Fulton Financial Corporation

HOLD

Current Price

$24.61

Market Cap

4.1B

Sector

Finance

ML Signal

HOLD

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$30.15

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FULT
PBLS
Founded
1882
N/A
Country
United States
United States
Employees
3400
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.6B
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
FULT
PBLS
Price
$24.61
$30.15
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$21.75
N/A
AVG Volume (30 Days)
2.0M
545.1K
Earning Date
04-22-2026
N/A
Dividend Yield
3.55%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.39
N/A
Revenue Next Year
$5.52
N/A
P/E Ratio
$10.58
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.60
$25.56
52 Week High
$25.23
$33.65

Technical Indicators

Market Signals
Indicator
FULT
PBLS
Relative Strength Index (RSI) 60.73 56.09
Support Level $23.51 $26.96
Resistance Level $24.71 $30.90
Average True Range (ATR) 0.51 2.47
MACD -0.03 -0.11
Stochastic Oscillator 63.27 51.59

Price Performance

Historical Comparison
FULT
PBLS

About FULT Fulton Financial Corporation

Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: